The 2024 increase is the same as last year.The foundation’s annual survey of employer health benefits also found that only 18 ...

LONDON and NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicine company, today announced a poster presentation at ...

A large study of veterans with type 2 diabetes finds better short-term kidney outcomes with use of SGLT2 inhibitors vs GLP-1 receptor agonists.

American adults prefer dietary change as a weight loss method, over injectable weight loss drugs such as Ozempic, a survey says.

While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...

Skye Bioscience (NASDAQ: SKYE) is a micro-cap pharmaceutical company that is striving to become the next big thing in the ...

Doctors have issued a serious health warning over the extremely dangerous ‘faux-zempic’ as the weight loss drugs see an ...

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound ...

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

Popular weight-loss drugs like Ozempic are used to treat obesity and diabetes. Now, researchers found that these drugs also ...

The COVID-19 pandemic made the world realize the importance of investing in healthcare infrastructure and developing treatments for unmet ...

Facial volume loss and increased skin laxity were significant in the mid-cheek region after major weight loss, resulting in accelerated facial aging.